Clinical Chemistry

Papers
(The H4-Index of Clinical Chemistry is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Cardiac Troponin I or T for the Diagnosis of Myocardial Infarction and Prediction of Outcomes—Does It Matter?138
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication98
Persistently Positive Urine Amphetamines Confirmation Testing85
Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries83
Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?71
B-090 Evaluation of Clinical Serology Assays Through the Development of Linearity Materials for aHBs IgG, Rubella IgG, and Toxoplasma IgG70
Clinical Chemistry’s Invited Reviewers 202157
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology55
Unexpected Persistently Increased Intraoperative Parathyroid Hormone Concentrations in a Patient with Primary Hyperparathyroidism55
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests55
Low Free T4 in a 13-Year-Old Girl with Short Stature and Blurry Vision52
B-097 Storage Stability of HbA1c in Whole Blood Tubes at Room Temperature on the Abbott Alinity c Clinical Chemistry System51
B-247 Rapid and Field-deployable Microchip-based Real-time PCR for Hepatitis B Virus DNA Detection50
A-194 Intravenous Fluid Contamination of Basic Metabolic Panels Is Underrecognized by Manual Workflows49
A-292 The Use of Third-Party Controls During Covid-19 Pandemic: An Alternative to the Lack of Other Respiratory Infections48
B-255 Engineered Reverse Transcriptases and Taq DNA Polymerases Deliver Robust Yield in the Presence of Clinically Relevant Inhibitors48
A-339 Utomated Flow of a Non-invasive Fetal Gender Determination Lab-developed Molecular Test47
A-142 Comparison of Alinity c Hemoglobin A1c Immunoassay with Premier Hb9210 Automated HPLC Assay: Very Few Patients May be Outside Reportable Range Using Alinity c.46
B-305 A Novel Dilute-n-shoot Method for Quantitating Isotonitazene and Desmetonitazene in Human Urine By LC/MS46
B-276 Preservation of Proteomic Inflammatory Biomarkers signal in a Saliva Multiomic Buffer at Room Temperature45
A-117 Performance Evaluation of five Sentinel Diagnostics’ Assays on Beckman Coulter DxC 500 AU Clinical Chemistry Analyzer44
A-023 Performance Evaluation of the Atellica IM High-Sensitivity Troponin I Assay on the Atellica CI 1900 Analyzer44
A-377 The Selection and Implementation of POC Illicit Drug Toxicology Testing in Hamad Medical Corporation - Doha, Qatar44
B-011 Analytical Validation of a New Vasoactive Intestinal Peptide Radioimmunoassay43
A-390 Implementation of the New GEM Hemochron 100 Point-of-care Coagulation System for Heparin Monitoring During Cardiopulmonary Bypass Procedures38
B-080 Analytical Performance of ESPLINE HTLV-I/II37
B-110 Validation of Digital and Automated anti-dsDNA IFA Interpretations Using the dIFine Automated Fluorescent Microscope System37
Prenatal Hemoglobinopathy Evaluation36
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl36
Clinical Chemistry's Invited Reviewers 202435
A-173 Evaluation of Artificial Intelligence (AI)-assisted Flow Cytometry Analysis for Plasma Cell Neoplasms35
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-1935
A-143 Comparative Evaluation of K2EDTA Performance in Multinational Vacutainers: A Case Study of “DBO” by Schraubg and “BD” by Becton, Dickinson34
B-253 Using biomarkers in recurrent renal stone formers to detect silent stones34
0.030761003494263